No Additional Short-Term Risk of MS Relapse After COVID Vaccine

(MedPage Today) -- Short-term risk of multiple sclerosis (MS) relapse did not rise after COVID-19 vaccination, a preliminary analysis in Italy showed.
Among 324 MS patients who received the Pfizer-BioNTech COVID-19 mRNA vaccine (Comirnaty), six...